Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01362946 · ClinicalTrials.gov registry record · NA

Behavioral Treatment for Children With Conduct Problems and Callous-Unemotional Traits

A NA study of Conduct Disorder and Oppositional Defiant Disorder, sponsored by Florida International University.

Completed
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT01362946 is a NA study of Conduct Disorder and Oppositional Defiant Disorder that has completed, run by Florida International University. The registered enrollment target is 48 participants, below the 704-participant average among 11 other Conduct Disorder trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01362946, a NA study of Conduct Disorder and Oppositional Defiant Disorder, has completed, sponsored by Florida International University.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to modify behavior therapy so that it is optimized for children with conduct problems and callous-unemotional traits by emphasizing reward components and de-emphasizing punishment components.

Interventions

  • BEHAVIORAL Reward-Emphasized Treatment
  • BEHAVIORAL Standard Treatment

Study Locations (1)

Florida

  • Florida International University - Miami

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2012-01
Est. Completion 2012-08
Phase NA

Sponsor

Florida International University

89 total trials

What the Registry Record Tells You About NCT01362946

The ClinicalTrials.gov registry entry for NCT01362946 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 704-participant average among 11 other Conduct Disorder trials with a reported enrollment target (93% lower). The listed sponsor is Florida International University, which has 89 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Conduct Disorder appearing as the primary indexed condition, and to 2 interventions - of which Reward-Emphasized Treatment is the first listed.

NCT01362946 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT01362946 about?

NCT01362946 is a clinical study titled "Behavioral Treatment for Children With Conduct Problems and Callous-Unemotional Traits". The purpose of this study is to modify behavior therapy so that it is optimized for children with conduct problems and callous-unemotional traits by emphasizing reward components and de-emphasizing punishment components.

What is the current status of trial NCT01362946?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2012-01. Estimated completion is 2012-08.

What conditions does trial NCT01362946 study?

This clinical trial studies the following conditions: Conduct Disorder, Oppositional Defiant Disorder.

What interventions are being tested in trial NCT01362946?

The interventions under investigation include: Reward-Emphasized Treatment (BEHAVIORAL), Standard Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT01362946?

This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01362946 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Conduct Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.